1373. Activity of Ceftriaxone–Sulbactam–EDTA Against Multi-Drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) Collected from Various Hospitals in India

BACKGROUND: Ceftriaxone–Sulbactam–EDTA (CSE) is the first cephalosporin–β-lactamase inhibitor combination with an antibiotic resistance breaker–disodium edetate, recently evaluated in a Phase 3 clinical trial for treatment of adults with complicated urinary tract infections (NCT03477422). The additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Girotra, Ruchi, Pyasi, Anurag, Chaudhary, Manu, Patil, N S, Mir, Mohd Amin, Chaudhary, Saransh, Mandale, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252651/
http://dx.doi.org/10.1093/ofid/ofy210.1204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252651/
http://dx.doi.org/10.1093/ofid/ofy210.1204

Ejemplares similares